Wie hoch ist der Preis für Entia Biosciences, Inc. (ERGO)

Preis für Entia Biosciences, Inc. (ERGO) ist $0.0002

Wie hoch ist die Marktkapitalisierung für Entia Biosciences, Inc. (ERGO)

Marktkapitalisierung für Entia Biosciences, Inc. (ERGO) ist $6.73K

Entia Biosciences, Inc. (ERGO) Aktiensplits

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Kumulierter Multiplikator	Land
Royalty Pharma plc RPRX.US	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	SE
Ipsen S.A. IPN.PA	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	IT
Corcept Therapeutics Incorporated CORT.US	-	US

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land